The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 07, 2021

Filed:

Feb. 08, 2016
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Gregory Riggins, White Hall, MD (US);

Renyuan Bai, Joppa, MD (US);

Verena Staedtke, Baltimore, MD (US);

Avadhut D. Joshi, Baltimore, MD (US);

Tara Williamson, Baltimore, MD (US);

Assignee:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4184 (2006.01); A61K 9/16 (2006.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 31/192 (2006.01); A61K 31/473 (2006.01); A61K 45/06 (2006.01); A23L 33/10 (2016.01); A61P 35/00 (2006.01); G01N 21/35 (2014.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A23L 33/10 (2016.08); A61K 9/0056 (2013.01); A61K 9/1605 (2013.01); A61K 9/50 (2013.01); A61K 31/192 (2013.01); A61K 31/473 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A61P 35/00 (2018.01); C07B 2200/13 (2013.01); G01N 21/35 (2013.01);
Abstract

Mebendazole is an antiparasitic drug with over 40 years of safe use. Recently mebendazole was repurposed for glioblastoma therapy. Three polymorphs of mebendazole exist, but the relative polymorph content for existing drugs varies, and the therapeutic anti-cancer relevance of the different polymorphs was unknown. As an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations. Efficacy is further improved by combining mebendazole with a P-glycoprotein inhibitor. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent.


Find Patent Forward Citations

Loading…